Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2B 〉JHL Biotech, Inc.

JHL Biotech, Inc.

My Favorites
JHL Biotech is a biopharmaceutical company that develops biosimilars and accelerates the development programs of distinguished clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development to commercial manufacturing with both global and regional regulatory affairs expertise.

Founded in 2012, JHL is an innovator in biopharmaceuticals that utilizes breakthrough engineering and process technologies to provide high quality and affordable biosimilar medicines to patients in need and a formidable CDMO player for global and regional clients. JHL has submitted IND/CTA's to over 20+ countries/regions and has passed numerous Regulatory Audits/Inspections, including from the Taiwan FDA and EU Qualified Person (QP).

JHL Biotech's headquarter and Center of Excellence is located in Hsinchu, Taiwan. The Center of Excellence has passed EU QP and TFDA audits and is fully-capable of producing material for clinical and commercial purposes for CDMO clients, as well as for our own pipeline.

This site has a cell culture suite equipped with 2 x 50L and 2 x 500L bioreactors, both of which feed into the downstream suite, and JHL can manufacture up to forty 500L-scale batches per year at this facility. All-inclusive Process Development, Analytical Development, Formulation, and in-house QC Labs provide characterization and COA release capabilities under one roof.

Comprehensive Project Management Organization and Master Production Planning ensure the maximum batches per year are being utilized with zero wasted time between changeovers.
  • JAMES HUANG<br/>Exe. Chairman & CEO

    JAMES HUANG
    Exe. Chairman & CEO

    27+ years of biological executive and investment experience.
    MBA from Stanford University.
  • RONG CHEN, MD, Ph.D.<br/>CMO

    RONG CHEN, MD, Ph.D.
    CMO

    30+ years of medical/clinical experience.
    Ph.D. from Royal Adelaide Hospital, University of Adelaide, Australia.
  • YEN HSIEH<br/>Compliance Officer & VP

    YEN HSIEH
    Compliance Officer & VP

    20+ years of HR management experience.
    B.S. in Applied Mathematics from UC Berkeley.
  • ALLEN HO, Ph.D.<br/>Sr. Director of RA & AD

    ALLEN HO, Ph.D.
    Sr. Director of RA & AD

    20+ years of biotech research experience of which with 6+ years in Regulatory Affairs.
    Ph.D. in Chemistry from National Cheng Kung University, Taiwan.
  • MAHALIA CORRALES<br/>Sr. Director, PD

    MAHALIA CORRALES
    Sr. Director, PD

    20+ years serving in various leadership roles in Process Dev., Manufacturing, and DS Commercial Manufacturing.
    B.S. in Chemical Engineering from UCLA.
JHL Biotech is a biopharmaceutical company that develops biosimilars and accelerates the development programs of distinguished clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development to commercial manufacturing with both global and regional regulatory affairs expertise.

Founded in 2012, JHL is an innovator in biopharmaceuticals that utilizes breakthrough engineering and process technologies to provide high quality and affordable biosimilar medicines to patients in need and a formidable CDMO player for global and regional clients. JHL has submitted IND/CTA's to over 20+ countries/regions and has passed numerous Regulatory Audits/Inspections, including from the Taiwan FDA and EU Qualified Person (QP).

JHL Biotech's headquarter and Center of Excellence is located in Hsinchu, Taiwan. The Center of Excellence has passed EU QP and TFDA audits and is fully-capable of producing material for clinical and commercial purposes for CDMO clients, as well as for our own pipeline.

This site has a cell culture suite equipped with 2 x 50L and 2 x 500L bioreactors, both of which feed into the downstream suite, and JHL can manufacture up to forty 500L-scale batches per year at this facility. All-inclusive Process Development, Analytical Development, Formulation, and in-house QC Labs provide characterization and COA release capabilities under one roof.

Comprehensive Project Management Organization and Master Production Planning ensure the maximum batches per year are being utilized with zero wasted time between changeovers.